Quest Patent Research Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 16, 2026, reporting patent licensing fee revenue of $5,080,000 for the third quarter and a net income of $3,195,801 for that same period.
Key Highlights
- Q3 2026 patent licensing fees: $5,080,000, compared to $0 in Q3 2025, according to the filing.
- Q3 2026 net income: $3,195,801, or $0.60 per basic and diluted share, versus a net loss of $1,230,309 in Q3 2025.
- Nine-month net loss: $(1,857,986) for the nine months ended September 30, 2026, compared to a net loss of $(3,196,485) for the same period in 2025.
- Total assets: $14,046,958 as of September 30, 2026, up from $10,437,519 as of December 31, 2025.
- Accumulated deficit: $(36,732,166) as of September 30, 2026, versus $(34,874,180) as of December 31, 2025.
- Shares outstanding: 5,331,973 shares of common stock as of November 13, 2026.
- Funding liability: $26,409,381 as of September 30, 2026, up from $22,263,516 as of December 31, 2025.
Quest Patent Research Reports Q3 2026 Financial Results and Balance Sheet Position
Quest Patent Research Corporation (OTC:QPRC), a Delaware-incorporated patent licensing company headquartered in Rye, New York, reported patent licensing fees of $5,080,000 for the three months ended September 30, 2026, compared to no licensing revenue in the same quarter of 2025, according to the filing. The company derives its revenue from licensing its patent portfolio, which the balance sheet reflects at a net carrying value of $8,502,596 as of September 30, 2026, net of accumulated amortization of $6,584,404. Litigation and licensing expenses for the third quarter were $652,994, producing a gross profit of $4,427,006 for the period.
For the nine months ended September 30, 2026, the company reported total patent licensing fees of $7,080,000 and a net loss of $(1,857,986), or $(0.35) per share. The nine-month period included an income tax expense of $330,000, which the filing notes was not incurred in the comparable 2025 period. Selling, general and administrative expenses for the nine-month period were $3,318,757, compared to $2,654,773 in the nine months ended September 30, 2025. Total interest expense, net, for the nine months was $(558,406), according to the filing.
The company's balance sheet as of September 30, 2026 showed total current liabilities of $32,894,278, which included a funding liability of $26,409,381 and a loan payable to a related party of $2,796,500. Total stockholders' deficit attributable to Quest Patent Research Corporation was $(19,051,213) as of September 30, 2026. Cash and cash equivalents stood at $16,561 at quarter end, down from $192,606 at December 31, 2025. Accounts receivable rose to $5,493,480 from $8,251 over the same period. The filing identifies the company as a smaller reporting company and a non-accelerated filer. The filing notes that forward-looking statements are subject to risks and uncertainties described in the company's cautionary language.
What Was Disclosed
Quest Patent Research Corporation filed its quarterly report covering the period ended September 30, 2026, disclosing patent licensing revenues, operating results, balance sheet figures including a growing funding liability and stockholders' deficit, and share count information as of November 13, 2026.





Please wait processing your request...